← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Rutgers, The State University Of New Jersey
Newark
$19,108,599
Total funding
26
Grants
Funding over time
peak $8.6M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$17,833,326 · 16
NSF$1,270,273 · 9
DOE$5,000 · 1
By mechanism
—$19,108,599 · 26
Investigators at Rutgers, The State University Of New Jersey
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
PREDATORY BACTERIA, FROM BASIC RESEARCH TO APPLICATION$7,158,456
· FY2015 · Department of the Army
NEUROENDOCRINE DIFFERENTIATION AND ENZALUTAMIDE RESISTANCE IN PROSTATE CANCER$1,908,000
· FY2017 · Department of the Army
CINJ CLINICAL CONSORTIUM FOR PROSTATE CANCER RESEARCH$1,258,298
· FY2009 · Department of Defense
THE ROLE OF TRIM6 IN BREAST CANCER METABOLISM AND CANCER PREVENTION$1,192,500
· FY2018 · Department of the Army
ROLES OF SYNTHETIC VIABILITY IN BREAST CANCER DEVELOPMENT AND THERAPY$1,111,845
· FY2015 · Department of Defense
SOMATIC MUTATION RATE AS DETERMINANT OF BREAST CANCER PENETRANCE IN BRCA1/2 FAMILIAL CASES$908,334
· FY2019 · Defense Health Agency
REWIRING VERY LONG CHAIN FATTY ACID METABOLISM IN PANCREATIC TUMOR-ASSOCIATED MACROPHAGES TO OVERCOME KRAS-TARGETED THERAPY RESISTANCE$768,420
· FY2025 · Defense Health Agency
CHRONIC STRESS AND ITS EFFECT ON CANCER THERAPY: MECHANISM AND INTERVENTION$636,000
· FY2018 · Department of the Army
STUDY OF THE MOLECULAR SIGNALING OF CHRONIC STRESS IN PROMOTING BREAST CANCER DEVELOPMENT TO PREVENT AND REDUCE BREAST CANCER INCIDENCE$596,250
· FY2016 · Department of the Army
ENDOGENOUS RETROVIRUS EXPRESSION, CHROMATIN ABNORMALITIES AND RESPONSE TO IMMUNE CHECKPOINT BLOCKADE IN CLEAR CELL RENAL CELL CANCER$585,025
· FY2019 · Department of the Army
CAREER: Frailty Assessment for Older Adults with Walking Disabilities using Dynamical Modeling of Cardiac, Brain, and Motor Systems in Response to Provocative Testing$572,067
· FY2023 · ENG
INVESTIGATING FIELD CANCERIZATION IN NON-SMALL CELL LUNG CANCER SUBTYPE USING EMERGING GENOMIC APPROACHES$526,498
· FY2022 · Defense Health Agency
SOMATIC MUTATION RATE, GENOMIC INSTABILITY AND CLONAL EVOLUTION IN BRCA1/2 CARRIERS UNDERGOING PROPHYLACTIC RISK-REDUCING SURGERY TO ESTABLISH SEROUS TUBULAR INTRA-EPITHELIAL LESIONS (STIL) AS CANCER PRECURSORS$407,852
· FY2020 · Defense Health Agency
FUNCTIONAL CLASSIFICATION OF BRCA1 MISSENSE MUTATIONS FOR PARP INHIBITOR THERAPY$323,572
· FY2010 · Department of Defense
PHOSPHOPROTEOMIC ASSESSMENT OF THERAPEUTIC KINASES FOR PERSONALIZED THERAPY IN CASTRATION-RESISTANT PROSTATE CANCER$311,523
· FY2015 · Department of the Army
RAPID: Physicochemical Assessment of the Emitted Nanoparticles and inhalable fly ash from Los Angeles Wildland-Urban Interface (WUI) Fires and Impact on Environmental Health$200,000
· FY2025 · ENG
The effect of inorganic trace elements on dentin apatite$199,930
· FY2023 · MPS
ROLE OF AUTOPHAGY IN KERATIN HOMJEOSTASIS IN BREAST CANCER$105,981
· FY2011 · Department of Defense
Human intentional environmental exposure studies: what risks are acceptable, and to whom?$93,972
· FY2024 · SBE
I-Corps: An adjuvant to improve the safety and tolerability of stimulant medications$50,000
· FY2023 · TIP